Surgical rates in the era of biological therapy: up, down or unchanged?

Date publication

juillet 2017

Journal

Current opinion in gastroenterology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
Olivera P, Spinelli A, Gower-Rousseau C, Danese S, Peyrin-Biroulet L

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/28463854

Résumé

The aim of this review is to summarize data regarding surgical trends in inflammatory bowel disease in the prebiologic and biologic era, with a focus on population-based studies and randomized controlled trials (RCTs).

Mots clés

Biological Therapy, statistics & numerical data, Humans, Inflammatory Bowel Diseases, therapy, Proctocolectomy, Restorative, statistics & numerical data, Randomized Controlled Trials as Topic, Remission Induction, Secondary Prevention, Tumor Necrosis Factor-alpha, antagonists & inhibitors

Référence

Curr. Opin. Gastroenterol.. 2017 Jul;33(4):246-253